Sirnaomics

About

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

Gaithersburg,Maryland,United States
101 - 250
http://www.sirnaomics.com

Highlights

Details

Last Funding Type: Series E
Last Funding Money Raised: $105M
Industries: Biopharma,Biotechnology,Medical Device,Pharmaceutical
Founded date: Jan 1, 2007
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Sirnaomics, Inc.

Sirnaomics is a clinical-stage biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference (RNAi) technology.

The RNAi technology is used to discover and develop novel therapeutics with a focus on oncology, anti-fibrotic therapeutics, and viral infection. Its proprietary Polypeptide Nano-Particle (PNP) technology is used for small interfering RNA (siRNA) drug delivery. This technology allows accessing the tumor micro-environment (TME), as well as various cell types in the liver.

Sirnaomics was founded by Patrick Y. Lu and David M. Evans in 2007 and is based in Gaithersburg, Maryland.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$267M

Sirnaomics has raised a total of $267M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2021 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 1, 2021	Series E	$105M	2	Rotating Boulder Fund	—	Detail
Oct 23, 2020	Series D	$105M	7	River Head Capital Rotating Boulder Fund Walvax Biotechnology	—	Detail
Apr 29, 2019	Series C	$22M	4	CR-CP Life Science Fund	—	Detail
Jun 6, 2018	Series C	$25M	4	Guangzhou Yuexiu Industrial Investment Fund	—	Detail
Apr 28, 2016	Series B	$10M	1	Value Measured Investment Limited	—	Detail

Investments

Number of Investments

Number of Lead Investments

2

1

Sirnaomics has made 2 investments. Their most recent investment was on Mar 29, 2022, when RNAimmune raised $27M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Mar 29, 2022 RNAimmune	Series A	$27M	Biotechnology	Yes
Apr 21, 2021 RNAimmune	Seed	$10M	Biotechnology	—

Investors

Number of Lead Investors

Number of Investors

7

18

Sirnaomics is funded by 18 investors. Rotating Boulder Fund and River Head Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Rotating Boulder Fund	Yes	Series E
River Head Capital	Yes	Series D
Walvax Biotechnology	Yes	Series D
CR-CP Life Science Fund	Yes	Series C
Guangzhou Yuexiu Industrial Investment Fund	Yes	Series C
Value Measured Investment Limited	Yes	Series B
Founder H Fund	—	Series E
Alpha Win Capital	—	Series D
Hongtao Capital	—	Series D
Longmen Capital	—	Series D